Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
David Scadden
University of Tx Md Anderson Can Ctr, Department: Biology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Fate Therapeutics
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Please see attachment from Massachusetts General Hospital (sub-recipient).
Stromal Regulation of Bone Metastasis
RELEVANCE (See instructions): Prostate cancer is the most commonly diagnosed malignancy in men in the US, with the highest rate of mortality after lung cancer. The underlying mechanism for the the 'specific' organ preferences of metastatic spread is largely unknown, particularly in the case of prostate cancer metastasizing to skeleton/bone. Therefore this proposal is designed to determine the impact of tumor microenvironment in the emergence of bone metastasis and identify new therapies
Filed on September 06, 2013.
Tell us what you know about David Scadden's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
David Scadden filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| David Scadden | Harvard University | Conflict of Interest | Magenta Therapeutic | >$600,000 |
| David Scadden | University of Tx Md Anderson Can Ctr | Conflict of Interest | Fate Therapeutics | $5,000 - $9,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.